These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31686345)

  • 1. ASO Author Reflections: Major Morbidity After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies.
    Peacock O; Waters PS; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):415-416. PubMed ID: 31686345
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Pelvic Exenteration for Patients with Primary and Recurrent Pelvic Cancer.
    Kulu Y
    Ann Surg Oncol; 2019 May; 26(5):1350. PubMed ID: 30843159
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
    Kolbert G; Müller G; Kujath P; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
    Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
    Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.
    D'Addato F; Guercio E; Re A; Gatti M; Raspollini M; Proserpio D; Bellino R; Lanza A
    Eur J Gynaecol Oncol; 1988; 9(5):420-3. PubMed ID: 3224613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total pelvic exenteration with preservation of fecal continence.
    Brodsky JT; Sloane BB; Khanna OP
    J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration for advanced pelvic malignancies.
    Yu HH; Leong CH; Ong GB
    Aust N Z J Surg; 1976 Aug; 46(3):197-201. PubMed ID: 1070292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
    Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
    Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical approaches in locally advanced and recurrent pelvic malignancy.
    Collins D; Jones R; Griffiths B
    Eur J Surg Oncol; 2022 Nov; 48(11):2258-2262. PubMed ID: 35086682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration and its modifications.
    Rodriguwz-Bigas MA; Petrelli NJ
    Am J Surg; 1996 Feb; 171(2):293-8. PubMed ID: 8619471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
    Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
    In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
    Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
    Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of fluorescent ureteral navigation in total pelvic exenteration using a two-team approach for locally recurrent pelvic malignancies-A video vignette.
    Ogura A; Murata Y; Jinno T; Yoshikawa N; Kajiyama H; Ebata T
    Colorectal Dis; 2024 Apr; 26(4):812-813. PubMed ID: 38326712
    [No Abstract]   [Full Text] [Related]  

  • 19. Sacral resection for control of pelvic tumors.
    Temple WJ; Ketcham AS
    Am J Surg; 1992 Apr; 163(4):370-4. PubMed ID: 1373043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of advanced pelvic cancer by exenteration.
    Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
    Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.